Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-10-11
1998-06-09
Guzo, David
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4353201, 435325, 4351725, 536 231, 536 241, C12N 510, C12N 1511, C12N 1586, C12P 2100
Patent
active
057632170
ABSTRACT:
Methods for treatment, processes for preparing, and compositions for delivering selected nucleic acid sequences to cells, primarily of the treatment of neurological disorders and exploring neurological functions, are disclosed. In particular, the invention provides recombinant Herpesvirus vectors with a high rate of expression of selected nucleic acid sequences and/or a low cytopathicity and its associated methods and processes.
REFERENCES:
patent: 4769331 (1988-09-01), Roizman et al.
patent: 4859587 (1989-08-01), Roizman
patent: 5288641 (1994-02-01), Roizman
patent: 5328688 (1994-07-01), Roizman
Roizman et al. in Fields et al., eds., Fundamental Virology (New York: Raven Press, 1991), pp. 841-847.
"Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy," Orkin and Motulsky, Co-chairs, Dec. 7, 1995.
Altschul et al., "Basic Local Alignment Search Tool," J. Mol. Biol. 215:403-410, 1990.
Devereux et al., "A comprehensive set of sequence analysis programs for the VAX," Nucleic Acids Research 12(1):387-395, 1984.
Ishiguro et al., "Neuron-specific Expression of the Human Dopamine .beta.-Hydroxylase Gene Requires Both the cAMP-Response Element and a Silencer Region," Journal of Biological Chemistry 268(24):17987-17994, 1993.
Kraner et al., "Silencing the Type II Sodium Channel Gene: A Model for Neural-Specific Gene Regulation," Neuron 9:37-44, 1992.
Li et al., "A cell type-specific silencer in the human choline acetyltransferase gene requiring two distinct and interactive E boxes," Molecular Brain Research 30:106-114, 1995.
Li et al., "Cholinergic Neuron-Specific Expression of the Human Choline Acetyltransferase Gene Is Controlled by Silencer Elements," Journal of Neurochemistry 61:748-751, 1993.
Li et al., "Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene," Proc. Natl. Acad. Sci. USA 90: 1460-1464, 1993.
Mori et al., "A Common Silencer Elements in the SCG10 and Type II Na.sup.+ Channel Genes Binds a Factor Present in Nonneuronal Cells but Not in Neuronal Cells," Neuron 9:45-54, 1992.
Pathak et al., "The presence of both negative and positive elements in the 5'-flanking sequence of the rat Na,K-ATPase .alpha.3 subunit gene are required for brain expression in transgenic mice," Nucleic Acid Research 22(22):4748-4755, 1994.
Schoenherr and Anderson, "The Neuron-Restrictive Silencer Factor (NRSF): A Coordinate Repressor of Multiple Neuron-Specific Gene," Science 267: 1360-1363, 1995.
Brinbaumer et al., "Receptor-effector coupling by G proteins," Biochimica et Biophysica Acta 1031: 163-224, 1990.
Cotechhia et al., "Molecular cloning and expression of the cDNA for the hamster .alpha..sub.1 -adrenergic receptor," Proc. Natl. Acad. Sci. USA 85: 7159-63, 1988.
Schwinn et al., "Molecular Cloning and Expression of the cDNA for a Novel .alpha..sub.1 -Adrenergic Receptor Subtype," Journal of Biological Chemistry 265(14):8183-89, 1990.
Kobilka et al., "Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet .alpha..sub.2 -Adrenergic Receptor," Science 238: 650-56, 1987.
Lomasney et al., "Expansion of the .alpha..sub.2 -adrenergic receptor family: Cloning and characterization of human .alpha..sub.2 -adrenergic receptor subtype, the gene for which is located on chromosome 2," Proc. Natl. Acad. Sci. USA 87:5094-98, 1990.
Regan et al., "Cloning and expression of human kidney cDNA for an .alpha..sub.2 -adrenergic receptor subtype," Proc. Natl. Acad. Sci. 85:6301-6305, 1988.
Weinshank et al., "Cloning, Expression, and Pharmacological Characterization of a Human .alpha..sub.2B -Adrenergic Receptor," Molecular Pharmacology 38:681-688, 1990.
Frielle et al., "Cloning of the cDNA for the human .beta..sub.1 -adrenergic receptor," Proc. Natl. Acad. Sci. USA 84: 7920-7924, 1987.
Dixon et al., "Cloning of the gene and cDNA for the mammalian .beta.-adrenergic receptor and homology with rhodopsin," Nature 321:75-79, 1986.
Emorine et al., "Molecular Characterization of the Human .beta..sub.3 -Adenergic Receptor," Science 245: 1118-1121, 1989.
Gatzke et al., "Generation of Herpes Simplex Virus Recombinants for Altering Expression of Neurotransmitter Receptors in Infected Cells," Society for Neuroscience Abstracts 19 (part 2):1339, abstract 551.7, 1993.
Meaney et al., "Development of Herpes Simplex Vectors for Virus-Mediated Gene Suppression in the CNS," J. Cell. Biochem. Suppl. 17E:202, abstract S 207, 1993.
Leib and Olivo, "Gene Delivery to Neurons: Is Herpes Simplex Virus the Right Tool for the Job?," BioEssays 15(8):547-554, 1993.
Johnson et al., "Cytotoxicity of a Replication-Defective Mutant of Herpes Simplex Virus Type 1," Journal of Virology 66(5):2952-2965, 1992.
Battleman et al., "HSV-1 Vector-Mediated Gene Transfer of the Human Nerve Growth Factor Receptor p75.sup.hNGFR Defines High-Affinity NGF Binding," Journal of Neuroscience 13(3):941-951, 1993.
Julius et al., "The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors," Proc. Natl. Acad. Sci. USA 87:928-932, 1990.
Glorioso et al., "Gene Transfer to Brain Using Herpes Simplex Virus Vectors," Annals of Neurology 35(Supp.):S28-S34, 1994.
Martin, J., "Gene therapy and pharmacological treatment of inherited neurological disorders," Trends in Biotechnology 13: 28-35, 1995.
Wood et al., "Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors," Gene Therapy 1(5):283-291, 1994.
Johnson et al., "Improved Cell Survival by the Reduction of Immediate-Early Gene Expression in Replication-Defective Mutants of Herpes Simplex Virus Type 1 but Not by Mutation of the Virion Host Shutoff Function," Journal of Virology 68(10):6347-6362, 1994.
Cynader Max
Tufaro Francis
Guzo David
Railey II Johnny F.
University of British Columbia
LandOfFree
Method of using, process of preparing and composition comprising does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using, process of preparing and composition comprising, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using, process of preparing and composition comprising will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2197846